series-c-plus
Stage
2
Investors
About
Kromatid provides high-confidence, single-cell genomic characterization and analysis for cell and gene therapy development to assess genomic integrity, structural variants, and transgene integration across the product lifecycle.
Explore Kromatid's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.